Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2016-01-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD)
NCT02327585
A Randomized Controlled Study of Family Based EF Training for Schoolage Children With ADHD
NCT05025501
Effects of an Aerobic Exercise Intervention on Core Symptoms, Executive Functioning, and Quality of Life in Children With Attention Deficit Hyperactivity Disorder
NCT06553430
The Feasibility of a Brief Attention Training Technique in Improving Behaviour and Attention in Children With ADHD
NCT02516917
Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.
NCT06369714
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Executive function training
the experimental group will receive 12 sessions of intensive Executive function training weekly immediately
intensive Executive function training
Children diagnosis of attention deficit hyperactivity disorder are randomized to the experimental condition(Executive Function training) or waiting group experimental:participants will receive 12 sessions of intensive executive function training weekly no intervention :waiting participants will not be treated with intensive executive function training and keep waiting for 12 weeks for comparison
the waitlist group
the waitlist group will wait 12 weeks before receiving intensive executive function training for comparison.
intensive Executive function training
Children diagnosis of attention deficit hyperactivity disorder are randomized to the experimental condition(Executive Function training) or waiting group experimental:participants will receive 12 sessions of intensive executive function training weekly no intervention :waiting participants will not be treated with intensive executive function training and keep waiting for 12 weeks for comparison
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intensive Executive function training
Children diagnosis of attention deficit hyperactivity disorder are randomized to the experimental condition(Executive Function training) or waiting group experimental:participants will receive 12 sessions of intensive executive function training weekly no intervention :waiting participants will not be treated with intensive executive function training and keep waiting for 12 weeks for comparison
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* full-scale intelligence quotient (FSIQ) ≥70
* stable on medication for attention deficit hyperactivity disorder children at least 3 months
* participation in the early implementation of functional training one year before
Exclusion Criteria
* a diagnosis of schizophrenia, epilepsy, mental retardation or other brain disorders
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ZIli Fan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ZIli Fan
postgraduate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ying Qian
Role: PRINCIPAL_INVESTIGATOR
Peking University Sixth Hospital/Institute of Mental Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Sixth Hospital/Institute of Mental Health
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Z151100004015103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.